ALPHA TRIBE

Astec LifeSciences LimitedBoard Meeting, 30-01-2026: Outcome of Board Meeting

30-01-2026 | 05:49 pm

Astec LifeSciences announced its board meeting decisions: approved the financial results for the quarter and nine-month period. Consolidated Q3 revenue hit ₹124.72 Cr, with a loss of ₹15.69 Cr. Mugdha Khare resigned as CFO, effective March 6, 2026, with Deepak Ochani taking over from April 1, 2026.

No comments yet. Be the first to comment!

All announcements from Astec LifeSciences Limited